James Investment Research’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,100
Closed -$20K 380
2023
Q1
$20K Hold
2,100
﹤0.01% 436
2022
Q4
$25K Buy
+2,100
New +$23.2K ﹤0.01% 430

Other funds holding HHS

James Investment Research's HHS Position: Q2 2023 in Review

James Investment Research sold out of Harte-Hanks (HHS) in Q2 2023, closing a stake of 2,100 shares — an estimated $20K sold.

James Investment Research first reported a position in HHS in Q4 2022 and held it in 2 quarters. The position peaked at $25K in Q4 2022. 30 funds tracked by Wall St. Rank hold HHS as of Q2 2023.

  • James Investment Research reported no remaining Harte-Hanks position as of Q2 2023 after selling out during the quarter.
  • James Investment Research sold 2,100 Harte-Hanks shares in Q2 2023, an estimated $20K.
  • James Investment Research first reported a position in Harte-Hanks in Q4 2022 and held it in 2 quarters.
  • James Investment Research's Harte-Hanks position peaked at $25K in Q4 2022.
  • 30 funds tracked by Wall St. Rank held Harte-Hanks as of Q2 2023.

Based on James Investment Research's 13F filing for Q2 2023, filed 7 Aug 2023.